Vertero Therapeutics

This study tests whether a new oral drug, AX-5006, is safe and tolerable in healthy adults and people with Parkinson's disease. It involves three parts: single doses, multiple doses over a week, and daily doses for 28 days. The goal is to gather safety data before larger trials.

This study looks at a gene called csgA found in gut bacteria of people with Parkinson's disease who have or had gut problems. Researchers want to know how common this gene is and how it changes over time. The goal is to learn more about the gut's role in Parkinson's, which could …